Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lingqiao Jiedu Wan is an approved traditional Chinese medicine (TCM) product manufactured by Liaoning Jindan Pharmaceutical. It is a modified version of the classical Yinqiao Jiedu formula, specifically enriched with *Cornu Saigae Tataricae* (Antelope Horn) to enhance its heat-clearing and sedative properties. The medication is primarily indicated for the treatment of "wind-heat" type common cold and influenza, characterized by symptoms such as high fever, headache, cough, sore throat, and thirst. In TCM theory, it functions to expel pathogenic wind, clear internal heat, and resolve toxins. The product is typically formulated as pills (Wan) for oral administration and is widely used in China for acute respiratory infections presenting with significant febrile symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lingqiao Jiedu Wan.